Home
>
US Stocks
>
Adaptimmune Therapeutics Plc - ADR
Adaptimmune Therapeutics Plc - ADR
ADAP

Adaptimmune Therapeutics Plc - ADR

$5.335.54%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.45
Today Low/High
5.28 / 5.45
52 Week Low/High
$3.37 / $10.93
Market Cap
$604.06M

Company Details

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
Organisation
Adaptimmune Therapeutics Plc - ADR
Headquaters
Abingdon, Oxfordshire, United Kingdom
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Adaptimmune Therapeutics Plc - ADR share price today

Can Indians buy Adaptimmune Therapeutics Plc - ADR shares?

How can I buy Adaptimmune Therapeutics Plc - ADR shares from India?

Can Fractional shares of Adaptimmune Therapeutics Plc - ADR be purchased?

What are the documents required to start investing in Adaptimmune Therapeutics Plc - ADR stocks?

We are a SEBI registered investement advisor